Clinical and functional outcomes of arthroscopic autologous collagen-induced chondrogenesis (ACIC) for osteochondral lesions of the talus: A retrospective case series.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 41607495.
- Also identified by DOI 10.1002/jeo2.70642 and PMC identifier 12841595.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The aim of this retrospective study was to assess the clinical outcomes for osteochondral lesions of the talus (OLT) treated with all arthroscopic autologous collagen-induced chondrogenesis (ACIC) technique using an injectable collagen scaffold combined with microfractures. Between 2020 and 2023, 21 patients with Hepple Grade II-IV OLTs underwent arthroscopic ACIC technique using an injectable collagen scaffold combined with microfractures. Concomitant intra-articular pathologies identified during arthroscopy were addressed simultaneously. Clinical outcomes, including Visual Analogue Scale (VAS), Foot Functional Index (FFI) and Foot and Ankle Ability Measure-Sports subscale (FAAM-SS), were assessed preoperatively and at the latest follow-up. Patient expectations, complications and return-to-activity times were also recorded at final follow-up. The mean follow-up was 37.4 ± 20.7 (range, 13-68) months. The mean defect size was 76.6 ± 33.6 mm<sup>2</sup> (range, 35-135 mm<sup>2</sup>). All clinical scores significantly improved compared with preoperative values (<i>p</i> < 0.05): VAS improved from 3.17 ± 1.82 (95% confidence interval [CI]: 2.34-4.00) to 0.27 ± 0.48 (95% CI 0.05-0.49), FFI from 40.90 ± 25.42 (95% CI: 29.33-52.47) to 4.02 ± 3.86 (95% CI: 2.26-5.78) and FAAM-SS from 37.81 ± 28.51 (95% CI: 24.83-50.79) to 86.11 ± 13.75 (95% CI: 79.85-92.37). All patients reported that their expectations were met or exceeded regarding pain relief, functional recovery and return to daily activities. Associated intra-articular pathologies were identified in all patients; in 17 patients (80.9%), a concomitant lateral ligament injury was observed and treated with arthroscopic repair. No major complications or revision surgeries occurred. Arthroscopic ACIC with an injectable atelocollagen scaffold was feasible and safe in this series of Hepple II-IV OLT, yielding improvements in patient‑reported outcomes at a mean 37.4‑month follow‑up. Due to design limitations and frequent concomitant ligament stabilization, these findings should be considered hypothesis‑generating rather than definitive evidence of cartilage regeneration. Level IV, retrospective case series.